Aimei Health Technology CO., LTD. 8-K Filing
Ticker: AFJKR · Form: 8-K · Filed: Dec 2, 2025 · CIK: 1979005
| Field | Detail |
|---|---|
| Company | Aimei Health Technology CO., LTD. (AFJKR) |
| Form Type | 8-K |
| Filed Date | Dec 2, 2025 |
| Pages | 7 |
| Reading Time | 9 min |
| Key Dollar Amounts | $0.0001, $150,000, $80,000, $0.033, $11.37 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Aimei Health Technology CO., LTD. (ticker: AFJKR) to the SEC on Dec 2, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.0001 (registered Ordinary Shares, par value $0.0001 per share AFJK The Nasdaq Stock Mar); $150,000 (ation (" Extension "), is adjusted from $150,000 for all outstanding ordinary shares sol); $80,000 (to an amount equal to the lesser of (i) $80,000 for all outstanding Public Shares and (); $0.033 (all outstanding Public Shares and (ii) $0.033 for each outstanding Public Share for e); $11.37 (res for cash at an approximate price of $11.37 per share, for an aggregate of approxim).
How long is this filing?
Aimei Health Technology CO., LTD.'s 8-K filing is 7 pages with approximately 2,190 words. Estimated reading time is 9 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 2,190 words · 9 min read · ~7 pages · Grade level 15.2 · Accepted 2025-12-02 16:05:43
Key Financial Figures
- $0.0001 — registered Ordinary Shares, par value $0.0001 per share AFJK The Nasdaq Stock Mar
- $150,000 — ation (" Extension "), is adjusted from $150,000 for all outstanding ordinary shares sol
- $80,000 — to an amount equal to the lesser of (i) $80,000 for all outstanding Public Shares and (
- $0.033 — all outstanding Public Shares and (ii) $0.033 for each outstanding Public Share for e
- $11.37 — res for cash at an approximate price of $11.37 per share, for an aggregate of approxim
- $44.8 million — hare, for an aggregate of approximately $44.8 million. Following the payment of the redemptio
- $0.7 million — nt will have a balance of approximately $0.7 million and the Company will have 2,179,072 sh
Filing Documents
- form8-k.htm (8-K) — 77KB
- ex3-1.htm (EX-3.1) — 13KB
- ex10-1.htm (EX-10.1) — 31KB
- 0001493152-25-025731.txt ( ) — 351KB
- afjk-20251126.xsd (EX-101.SCH) — 4KB
- afjk-20251126_def.xml (EX-101.DEF) — 27KB
- afjk-20251126_lab.xml (EX-101.LAB) — 37KB
- afjk-20251126_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 7KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 2, 2025 Aimei Health Technology Co., Ltd By: /s/ Junheng Xie Name: Junheng Xie Title: Chief Executive Officer